Rapid scientific advances are accelerating the development of medical innovations, from personalized treatments to curative ...

Medicus Pharma Ltd ( ($MDCX) ) has provided an announcement. Medicus Pharma Ltd. has completed the acquisition of Antev Limited, a UK-based ...

New draft guidelines suggest the FDA is open to exercising regulatory flexibility for non-opioid drugs being developed for chronic pain.

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Formulation development strategies are influenced by problem-solving, digital tools, and geopolitical changes, highlighting ...

Keensight Capital portfolio company Symeres has acquired DGr Pharma, a drug development-focused company, to expand its integrated early-stage drug development services and accelerate IND-enabling ...

NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their ...

Amneal is a pharma brand with a diverse and growing drug portfolio, strong cash flow metrics, and an improving debt situation ...

- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance Daewoong Pharmaceutical's drug discovery ...

Recursion Pharmaceuticals (NASDAQ:RXRX) has seen significant share price volatility in 2025, dropping 27% year-to-date and trading over 55% below its 52-week high of $12. Despite this underperformance ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced that it is leveraging Lantern Pharma's breakthrough PredictBBB.ai™ platform, a next-generation ...